Science Explorer Back to mapMap

Most cited papers from Ontario Brain Institute

What are the most cited papers from Ontario Brain Institute?

The most cited paper from Ontario Brain Institute is "The prevalence of Parkinson's disease: A systematic review and meta‐analysis" (Tamara M. Pringsheim, Nathalie Jetté, Alexandra D. Frolkis et al., 2014), with 2,214 citations. Next come "Uneven Pattern of Dopamine Loss in the Striatum of Patients with Idiopathic Parkinson's Disease" (1,973) and "Mechanisms of stress in the brain" (1,437).

Showing 50 of 60 papers. Every paper with more than 241 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 The prevalence of Parkinson's disease: A systematic review and meta‐analysis Tamara M. Pringsheim, Nathalie Jetté, Alexandra D. Frolkis et al. · Movement Disorders Review 28 Jun 2014 2,214
2 Uneven Pattern of Dopamine Loss in the Striatum of Patients with Idiopathic Parkinson's Disease Stephen J. Kish, Kathleen S. Shannak, Oleh Hornykiewicz · New England Journal of Medicine 7 Apr 1988 1,973
3 Mechanisms of stress in the brain Bruce S. McEwen, Nicole P. Bowles, Jason D. Gray et al. · Nature Neuroscience Open access 25 Sep 2015 1,437
4 Elevated depression and anxiety symptoms among pregnant individuals during the COVID-19 pandemic Catherine A. Lebel, Anna MacKinnon, Mercedes Bagshawe et al. · Journal of Affective Disorders Open access Aug 2020 1,058
5 Multiple dopamine D4 receptor variants in the human population Hubert H.M. Van Tol, Caren M. Wu, Hong‐Chang Guan et al. · Nature Jul 1992 969
6 The Cambridge Centre for Ageing and Neuroscience (Cam-CAN) data repository: Structural and functional MRI, MEG, and cognitive data from a cross-sectional adult lifespan sample Jason R. Taylor, Nitin Williams, Rhodri Cusack et al. · NeuroImage Open access 13 Sep 2015 884
7 Modulation of Intracellular Cyclic AMP Levels by Different Human Dopamine D4 Receptor Variants Vida Asghari, Suparna Sanyal, Saskia Buchwaldt et al. · Journal of Neurochemistry Sep 1995 864
8 Functions of the Frontal Lobes: Relation to Executive Functions Donald T. Stuss · Journal of the International Neuropsychological Society 24 May 2011 786
9 Vascular dysfunction—The disregarded partner of Alzheimer's disease Melanie D. Sweeney et al. · Alzheimer s & Dementia Open access 2019 745
10 Clinical and Theoretical Implications of 5-HT2 and D2 Receptor Occupancy of Clozapine, Risperidone, and Olanzapine in Schizophrenia Shitij Kapur, Robert B. Zipursky, Gary Remington · American Journal of Psychiatry Feb 1999 715
11 Stroke genetics informs drug discovery and risk prediction across ancestries Aniket Mishra et al. · Nature Open access592 authors 30 Sep 2022 637
12 The dynamic pain connectome Aaron K. Kucyi, Karen Deborah Davis · Trends in Neurosciences Review 22 Dec 2014 601
13 Repetitive Transcranial Magnetic Stimulation for the Acute Treatment of Major Depressive Episodes ANDRÉ RUSSOWSKY BRUNONI, Anna Chaimani, Adriano H. Moffa et al. · JAMA Psychiatry 28 Dec 2016 530
14 Discovery and validation of biomarkers to aid the development of safe and effective pain therapeutics: challenges and opportunities Karen Deborah Davis et al. · Nature Reviews Neurology ReviewOpen access 15 Jun 2020 512
15 Advances in diagnosis, classification, pathophysiology, and management of trigeminal neuralgia Lars Bendtsen, Joanna M. Zakrzewska, Tone Bruvik Heinskou et al. · The Lancet Neurology 18 Aug 2020 504
16 Distribution patterns of tau pathology in progressive supranuclear palsy Gábor Géza Kovács et al. · Acta Neuropathologica Open access 7 May 2020 502
17 A systematic review and meta-analysis on the epidemiology of Duchenne and Becker muscular dystrophy Jean Kit-Wah Mah, Lawrence W. Korngut, Jonathan Dykeman et al. · Neuromuscular Disorders Review 23 Mar 2014 497
18 Appraisal of the self-schema construct in cognitive models of depression. Zindel V. Segal · Psychological Bulletin 1988 469
19 White matter hyperintensities in vascular contributions to cognitive impairment and dementia (VCID): Knowledge gaps and opportunities Jessica Alber et al. · Alzheimer s & Dementia Translational Research & Clinical Interventions Open access 2019 460
20 Alcohol use and dementia: a systematic scoping review Jürgen T. Rehm, Omer S. M. Hasan, Sandra E. Black et al. · Alzheimer s Research & Therapy Open access 5 Jan 2019 457
21 An optimized acetylcholine sensor for monitoring in vivo cholinergic activity Miao Jing et al. · Nature Methods Open access 28 Sep 2020 456
22 Equivalency of the diagnostic accuracy of the PHQ-8 and PHQ-9: a systematic review and individual participant data meta-analysis Yin Wu et al. · Psychological Medicine ReviewOpen access 12 Jul 2019 438
23 Mind wandering away from pain dynamically engages antinociceptive and default mode brain networks Aaron K. Kucyi, Tim Vaughn Salomons, Karen Deborah Davis · Proceedings of the National Academy of Sciences Open access 28 Oct 2013 418
24 Guidelines of the International Headache Society for controlled trials of preventive treatment of chronic migraine in adults Cristina Tassorelli, Hans‐Christoph Diener, David W. Dodick et al. · Cephalalgia Open access 4 Mar 2018 402
25 Clinical, imaging, and pathological heterogeneity of the Alzheimer's disease syndrome Benjamin Lam, Mario Masellis, Morris Freedman et al. · Alzheimer s Research & Therapy Open access 2013 397
26 Symptoms of professional burnout: A review of the empirical evidence. Sophia Kahill · Canadian Psychology/Psychologie canadienne Jul 1988 397
27 Neuropsychiatric symptoms in Alzheimer's disease: Past progress and anticipation of the future Yonas E. Geda et al. · Alzheimer s & Dementia Open access 4 Apr 2013 384
28 Dynamic functional connectivity of the default mode network tracks daydreaming Aaron K. Kucyi, Karen Deborah Davis · NeuroImage 25 Jun 2014 384
29 An international two–stage genome–wide search for schizophrenia susceptibility genes Hans W. Moises et al. · Nature Genetics Nov 1995 378
30 Preprocessing, analysis and quantification in single‐voxel magnetic resonance spectroscopy: experts' consensus recommendations Jamie Near, Ashley D. Harris, Christoph Juchem et al. · NMR in Biomedicine Open access 21 Feb 2020 375
31 Levodopa‐induced dyskinesia in Parkinson disease: Current and evolving concepts Alberto J. Espay, Francesca Morgante, Aristide Merola et al. · Annals of Neurology Open access 24 Oct 2018 346
32 Morphine catalepsy in the rat: relation to striatal dopamine metabolism K. Kuschiski, Oleh Hornykiewicz · European Journal of Pharmacology Jul 1972 339
33 Therapeutic alliance rupture as a therapy event for empirical investigation. Jeremy D. Safran, Peter R.E. Crocker, Shelly McMain et al. · Psychotherapy 1990 336
34 Guidelines for the Pharmacotherapy of Schizophrenia in Adults Gary J. Remington, Donald Emile Addington, William G. Honer et al. · The Canadian Journal of Psychiatry Open access 13 Jul 2017 334
35 The validity of classification for the clinical presentation of intracranial dural arteriovenous fistulas Mark Davies, Karel G. terBrugge, Robert A. Willinsky et al. · Journal of neurosurgery Nov 1996 327
36 Predicting optimal deep brain stimulation parameters for Parkinson’s disease using functional MRI and machine learning Alexandre Boutet, Radhika Madhavan, Gavin J.B. Elias et al. · Nature Communications Open access 24 May 2021 314
37 Oral Treatment with Live Lactobacillus reuteri Inhibits the Allergic Airway Response in Mice Paul Forsythe, Mark D. Inman, John Bienenstock · American Journal of Respiratory and Critical Care Medicine 4 Jan 2007 308
38 Salient private audiences and awareness of the self. Mark W. Baldwin, John G. Holmes · Journal of Personality and Social Psychology Jun 1987 305
39 Catalyzing next-generation Artificial Intelligence through NeuroAI Anthony M. Zador et al. · Nature Communications Open access 22 Mar 2023 303
40 Glutathione peroxidase activity in Parkinson's disease brain Stephen J. Kish, Caryl L. H. Morito, Oleh Hornykiewicz · Neuroscience Letters Aug 1985 303
41 Complications of epilepsy surgery—A systematic review of focal surgical resections and invasive EEG monitoring Walter J Hader, José Francisco Téllez‐Zenteno, Amy Metcalfe et al. · Epilepsia ReviewOpen access 3 Apr 2013 301
42 Depressive-like behavior induced by tumor necrosis factor-α in mice Manuella Pinto Kaster, Vinícius M. Gadotti, João Β. Calixto et al. · Neuropharmacology 21 Aug 2011 295
43 The Prevalence and Incidence of Frontotemporal Dementia: a Systematic Review David B. Hogan, Nathalie Jetté, Kirsten Marie Fiest et al. · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques ReviewOpen access Apr 2016 288
44 The neurobiology of impulsivity and substance use disorders: implications for treatment Karolina Kozak, Aliya M. Lucatch, Darby J. E. Lowe et al. · Annals of the New York Academy of Sciences Open access 5 Oct 2018 287
45 The Prevalence and Incidence of Dementia Due to Alzheimer’s Disease: a Systematic Review and Meta-Analysis Kirsten Marie Fiest, Jodie I. Roberts, Colleen Jean Maxwell et al. · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques ReviewOpen access Apr 2016 285
46 Frontostriatal salience network expansion in individuals in depression Charles J. Lynch et al. · Nature Open access 4 Sep 2024 284
47 The Cognitive Therapy Scale: Psychometric properties. Michael Vallis, Brian F. Shaw, Keith S. Dobson · Journal of Consulting and Clinical Psychology 1986 277
48 Aging Produces a Specific Pattern of Striatal Dopamine Loss: Implications for the Etiology of Idiopathic Parkinson's Disease Stephen J. Kish, Kathleen S. Shannak, Ali H. Rajput et al. · Journal of Neurochemistry Feb 1992 276
49 Brain S‐Adenosylmethionine Levels Are Severely Decreased in Alzheimer's Disease Lesley D. Morrison, David D. Smith, Stephen J. Kish · Journal of Neurochemistry Sep 1996 265
50 Evolving concepts on bradykinesia Matteo Bologna, Giulia Paparella, Alfonso A. Fasano et al. · Brain Open access 14 Oct 2019 260

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.